Group One Trading, L.P. Axsome Therapeutics, Inc. Transaction History
Group One Trading, L.P.
- $2.4 Billion
- Q3 2024
A detailed history of Group One Trading, L.P. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 50,141 shares of AXSM stock, worth $5.72 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
50,141Holding current value
$5.72 Million% of portfolio
0.19%Shares
27 transactions
Others Institutions Holding AXSM
# of Institutions
327Shares Held
38.1MCall Options Held
912KPut Options Held
855K-
Rtw Investments, LP New York, NY4.19MShares$478 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$455 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$376 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$269 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$119 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.89B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...